Detection of the Antiviral Drug Oseltamivir in Aquatic Environments
Open Access
- 26 June 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (6), e6064
- https://doi.org/10.1371/journal.pone.0006064
Abstract
Oseltamivir (Tamiflu®) is the most important antiviral drug available and a cornerstone in the defence against a future influenza pandemic. Recent publications have shown that the active metabolite, oseltamivir carboxylate (OC), is not degraded in sewage treatment plants and is also persistent in aquatic environments. This implies that OC will be present in aquatic environments in areas where oseltamivir is prescribed to patients for therapeutic use. The country where oseltamivir is used most is Japan, where it is used to treat seasonal flu. We measured the levels of OC in water samples from the Yodo River system in the Kyoto and Osaka prefectures, Japan, taken before and during the flu-season 2007/8. No OC was detected before the flu-season but 2–58 ng L−1 was detected in the samples taken during the flu season. This study shows, for the first time, that low levels of oseltamivir can be found in the aquatic environment. Therefore the natural reservoir of influenza virus, dabbling ducks, is exposed to oseltamivir, which could promote the evolution of viral resistance.Keywords
This publication has 12 references indexed in Scilit:
- Meeting Report: Risk Assessment of Tamiflu Use Under Pandemic ConditionsEnvironmental Health Perspectives, 2008
- Genetic Compatibility and Virulence of Reassortants Derived from Contemporary Avian H5N1 and Human H3N2 Influenza A VirusesPLoS Pathogens, 2008
- Antiviral Oseltamivir Is not Removed or Degraded in Normal Sewage Water Treatment: Implications for Development of Resistance by Influenza A VirusPLOS ONE, 2007
- Degradation of the antiviral drug oseltamivir carboxylate in surface water samplesInternational Journal of Environmental Analytical Chemistry, 2007
- Potential Risks Associated with the Proposed Widespread Use of TamifluEnvironmental Health Perspectives, 2007
- Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their UseAntimicrobial Agents and Chemotherapy, 2006
- Global Patterns of Influenza A Virus in Wild BirdsScience, 2006
- Dose adjustment in renal impairment: Response from Martindale: the Complete Drug ReferenceBMJ, 2005
- Influenza: Emergence and ControlJournal of Virology, 2004
- Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant VariantsAntimicrobial Agents and Chemotherapy, 2001